94 related articles for article (PubMed ID: 389502)
1. Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2).
Remuzzi G; Marchesi D; Cavenaghi AE; Livio M; Donati MB; de Gaetano G; Mecca G
Clin Nephrol; 1979 Sep; 12(3):127-31. PubMed ID: 389502
[TBL] [Abstract][Full Text] [Related]
2. Vascular factors in the pathogenesis of uraemic bleeding.
Remuzzi G; Bertani T; Livio M; Cavenaghi AE; Mysliwiec M; Marchesi D; Donati MC; de Gaetano G; Mecca G
Proc Eur Dial Transplant Assoc; 1978; 15():449-55. PubMed ID: 368787
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
Ylikorkala O; Huttunen K; Järvi J; Viinikka L
Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin-like activity and bleeding in renal failure.
Remuzzi G; Cavenaghi AE; Mecca G; Donati MB; de Gaetano G
Lancet; 1977 Dec; 2(8050):1195-7. PubMed ID: 73900
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
Kyrle PA; Stockenhuber F; Brenner B; Gössinger H; Korninger C; Pabinger I; Sunder-Plassmann G; Balcke P; Lechner K
Thromb Haemost; 1988 Oct; 60(2):205-8. PubMed ID: 2975407
[TBL] [Abstract][Full Text] [Related]
6. Increased production of prostacyclin after injury to the microvasculature in uraemic patients.
Slazus W
S Afr Med J; 1992 Mar; 81(6):315-7. PubMed ID: 1570581
[TBL] [Abstract][Full Text] [Related]
7. Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis.
Remuzzi G; Livio M; Cavenaghi AE; Marchesi D; Mecca G; Donati MB; de Gaetano G
Thromb Res; 1978 Sep; 13(3):531-6. PubMed ID: 369029
[No Abstract] [Full Text] [Related]
8. Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: effects of conjugated estrogens.
Zoja C; Viganò G; Bergamelli A; Benigni A; de Gaetano G; Remuzzi G
J Lab Clin Med; 1988 Sep; 112(3):380-6. PubMed ID: 2842417
[TBL] [Abstract][Full Text] [Related]
9. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
[TBL] [Abstract][Full Text] [Related]
10. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
Stuart MJ; Spitzer RE; Coppe D
Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
[No Abstract] [Full Text] [Related]
11. Treatment of bleeding in dialysis patients.
Galbusera M; Remuzzi G; Boccardo P
Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
[TBL] [Abstract][Full Text] [Related]
12. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
Jørgensen KA
Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257
[No Abstract] [Full Text] [Related]
13. Conjugated estrogens for the management of gastrointestinal bleeding secondary to uremia of acute renal failure.
Heunisch C; Resnick DJ; Vitello JM; Martin SJ
Pharmacotherapy; 1998; 18(1):210-7. PubMed ID: 9469696
[TBL] [Abstract][Full Text] [Related]
14. Study of "prostacyclin-like" activity in the rat blood vessel: changes in prostacyclin production related to body weight.
Horváth G; Benkö G
Acta Physiol Hung; 1984; 63(1):21-7. PubMed ID: 6430032
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
[TBL] [Abstract][Full Text] [Related]
16. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
Leithner C; Sinzinger H; Silberbauer K; Wolf A; Stummvoll HK; Pinggera W
Proc Eur Dial Transplant Assoc; 1980; 17():424-8. PubMed ID: 7017684
[TBL] [Abstract][Full Text] [Related]
17. Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.
Hanley SP; Hughes J
Thromb Haemost; 1983 Feb; 49(1):51-2. PubMed ID: 6342201
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts.
Baenziger NL; Becherer PR; Majerus PW
Cell; 1979 Apr; 16(4):967-74. PubMed ID: 110457
[No Abstract] [Full Text] [Related]
19. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
